Premium
P1‐012: Effect of ponezumab on CSF biomarkers: Pooled analysis of phase IIa studies in subjects with mild‐to‐moderate Alzheimer's disease
Author(s) -
Cronenberger Carol,
Schwartz Pam,
Wright Kathryn,
Bales Kelly,
Blennow Kaj,
Zetterberg Henrik,
Landen Jaren,
Styren Scot,
Chen Nathan,
Binneman Brendon
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2012.05.287
Subject(s) - biomarker , placebo , medicine , cerebrospinal fluid , pooled analysis , antibody , gastroenterology , oncology , immunology , pathology , confidence interval , chemistry , biochemistry , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom